Silicon Valley’s gene-editor Synthego files for bankruptcy with plans to sell itself to lenders

siliconvalley.com/2025/05/07/gene-editor-synthego-files-bankruptcy-with-plans-to-sell-itself-to-lenders

By Steven Church, Bloomberg
Synthego Corp., which makes gene-editing tools for drug developers and other researchers, filed for bankruptcy with plans to sell itself to its main lender, an affiliate of private equity firm Perceptive Advisors.
Related Articles



How AI and tech are…

This story appeared on siliconvalley.com, 2025-05-07 13:57:33.
The Entire Business World on a Single Page. Free to Use →